MedPath

Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates

Conditions
to Compare LIF Level in Cord Blood of Embryo's That Are IUGR to Those That Are AGA
Interventions
Other: blood sample and tissue sample
Registration Number
NCT02518126
Lead Sponsor
Rambam Health Care Campus
Brief Summary

To see if there is a relationship between the level of LIF in IUGR fetuses and compared to the level of LIF in AGA fetuses

Detailed Description

During embryonic development, there are several cytokines such as: LIF (Leukemia inhibitory factor), ciliary neurotrophic factor (CNTF), epidermal growth factor family (EGF), neuregulin 1 (NRG1) and transforming growth factor β (TGFβ) that were found are associated with neurogenesis and differentiation of brain cells .

LIF is a cytokine that is essential for the development of the central nervous system, and has recently been shown in rats that maternal LIF stimulates placental ACTH that in turn promotes secretion of fetal LIF from nRBC , which in turn promotes brain development of the fetus Other studies on IUGR (Intra Uterine Growth Restriction) have shown that IUGR fetuses have more CP (Cerebral palsy) than those who were AGA (Average for Gestational Age) The hypothesis is that LIF is related to the proper development of the nervous system in the fetus and by testing cord blood of embryos IUGR and the placenta we will find changes in LIF and ACTH compared with AGA fetuses level.

Studies have also shown a relationship between CP and IUGR, but the mechanism for this relationship is unclear.

The purpose of our research is to see if there is a relationship between the level of LIF in IUGR fetuses and compared to the level of LIF in AGA fetuses, in one of two ways:

* Changes in the secretion of ACTH in placenta

* Changes in levels of LIF in the umbilical cord blood

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Women that the Fetal weight estimate puts the fetus bellow the 10th percentile and those that the fetal weight estimate are between 20th and 80th percentiles
Exclusion Criteria
  • Women who do not agree
  • known Genetic diseases of abnormalities in the fetus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
controlblood sample and tissue sampleWomen with IUGR embryos so that their fetal weight estimate puts them in a percentile bellow 10th percentile
IUGRblood sample and tissue sampleWomen with AGA embryos so that their fetal weight estimate puts them in a percentile between 20th and 80th percentiles
Primary Outcome Measures
NameTimeMethod
LIF Protein Level in IUGR Neonates vs. AGA neonates2 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath